ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
University Medical Center GroningenUniversity of Groningen; Netherlands Organisation for Scientific ResearchRecruitingDepression in RemissionNetherlands
-
Medical University of ViennaNot yet recruitingVascular Access | Fistulas Arteriovenous | Haemodialysis Complication | End Stage Renal Failure, Hemodialysis | Haemodialysis Patients
-
National Institute of Allergy and Infectious Diseases...Fzata, IncNot yet recruitingClostridium Difficile Infection
-
National Taiwan University HospitalRecruitingCardiac Arrhythmias | Subclinical Atrial FibrillationTaiwan
-
Norroy Bioscience Co., LTDNot yet recruiting
-
University of MinnesotaNot yet recruitingStroke | Ischemic Stroke | Hemorrhagic Stroke
-
The Cleveland ClinicRecruitingHeart Failure | NYHA Class III Heart Failure | NYHA Class II Heart FailureUnited States
-
Massachusetts General HospitalMclean Hospital; Martinos Center for Biomedical ImagingRecruiting
-
Obstetrics & Gynecology Hospital of Fudan UniversityNot yet recruiting
-
ScinnoHub Pharmaceutical Co., Ltd.Not yet recruiting
-
Children's Hospital Medical Center, CincinnatiRecruiting
-
Gulf Medical UniversityRecruitingSoft Tissue Augmentation at Dental Implants | Connective Tissue Graft | Soft Tissue | PRF | Peri-Implant HealthUnited Arab Emirates
Clinical Research Jobs
-
Philippines - Manila
-
United States - Ohio - Cincinnati
-
United States - Richmond
-
China
-
Spain - MadridSpain - BarcelonaSpain - SevilleSpain - CadizSpain - MurciaSpainSpain - Galicia
-
Portugal - Lisbon
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China